IHH Annual Report 2023

Financial Statements Notes to the Financial Statements Name of subsidiary Place of incorporation and business Principal activities Effective ownership interest and voting interest 2023 % 2022 % Indirect subsidiaries (continued) Held through PCH Holding Pte. Ltd.: Medical Resources International Pte. Ltd. # Singapore Investment holding 70.10 70.10 M & P Investments Pte. Ltd. # Singapore Investment holding 70.10 70.10 Parkway (Shanghai) Hospital Management Ltd. # People’s Republic of China Provision of management and consultancy services to healthcare facilities 70.10 70.10 Held through M & P Investments Pte. Ltd.: ParkwayHealth Shanghai Hospital Company Limited # People’s Republic of China Provision of medical and health related facilities and services 49.07 49.07 Gleneagles Chengdu Hospital Company Limited # People’s Republic of China Provision of specialised care and services – 49.07 Held through Medi-Rad Associates Ltd.: Radiology Consultants Pte. Ltd. # Singapore Provision of radiology consultancy and interpretative services 100 100 Held through Gleneagles Development Pte. Ltd.: Gleneagles Healthcare India Pte. Ltd. (f.k.a. Ravindranath GE Medical Associates Private Limited) #^(4) India Private hospital ownership and management, specialty tertiary care including multi organ transplant healthcare facility 98.17 75.62 Parkway Healthcare India Private Limited #^(5) India Provision of management and consultancy services 100 100 Held through Gleneagles Healthcare India Pte. Ltd.: Centre for Digestive and Kidney Diseases (India) Private Limited #^ India Private hospital ownership and management, specialty tertiary care including multi organ transplant healthcare facility 62.62 49.14 Global Clinical Research Services Private Limited #^ India Provision of clinical research services 100 75.38 IHH Healthcare Berhad 238 41. SUBSIDIARIES (continued)

RkJQdWJsaXNoZXIy NDgzMzc=